Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.39M Buy
13,851
+26
+0.2% +$2.68K 0.09% 53
2024
Q3
$1.58M Sell
13,825
-4,848
-26% -$576K 0.11% 50
2024
Q2
$2.33M Sell
18,673
-5
-0% -$644 0.17% 39
2024
Q1
$2.48M Sell
18,678
-69
-0.4% -$8.51K 0.2% 35
2023
Q4
$2.06M Sell
18,747
-728
-4% -$75.6K 0.2% 32
2023
Q3
$2.02M Buy
19,475
+664
+4% +$71.6K 0.23% 28
2023
Q2
$2.18M Buy
18,811
+11,650
+163% +$1.32M 0.27% 27
2023
Q1
$767K Buy
7,161
+548
+8% +$59.2K 0.11% 40
2022
Q4
$738K Buy
6,613
+931
+16% +$95.2K 0.13% 40
2022
Q3
$493K Sell
5,682
-1,223
-18% -$109K 0.11% 47
2022
Q2
$634K Sell
6,905
-3
-0% -$266 0.13% 43
2022
Q1
$572K Sell
6,908
-508
-7% -$40.1K 0.11% 51
2021
Q4
$573K Buy
7,416
+28
+0.4% +$2.23K 0.11% 55
2021
Q3
$560K Buy
7,388
+512
+7% +$38.9K 0.12% 53
2021
Q2
$539K Sell
6,876
-196
-3% -$14.6K 0.12% 48
2021
Q1
$525K Buy
7,072
+1,279
+22% +$94.3K 0.12% 46
2020
Q4
$638K Hold
5,793
0.16% 32
2020
Q3
$462K Sell
5,793
-36
-0.6% -$2.82K 0.13% 36
2020
Q2
$434K Buy
5,829
+800
+16% +$60.2K 0.13% 38
2020
Q1
$372K Buy
5,029
+1,895
+60% +$149K 0.11% 33
2019
Q4
$274K Buy
3,134
+165
+6% +$13.6K 0.08% 40
2019
Q3
$240K Buy
+2,969
New +$238K 0.09% 56
2016
Q4
Sell
-4,651
Closed -$277K 28
2016
Q3
$277K Buy
+4,651
New +$272K 0.16% 22

Other funds holding MRK

Geller Advisors's MRK Position: Q4 2024 in Review

Geller Advisors increased its Merck (MRK) stake by 0.19% in Q4 2024, buying an estimated $2.68K and bringing the position to 13,851 shares worth $1.39M. The position accounts for 0.09% of the portfolio, ranked #53.

Geller Advisors first reported a position in MRK in Q3 2016 and has held it in 23 quarters since. The position peaked at $2.48M in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Geller Advisors held 13,851 shares of Merck worth $1.39M as of Q4 2024.
  • Geller Advisors bought 26 Merck shares in Q4 2024, an estimated $2.68K.
  • Merck made up 0.09% of Geller Advisors's portfolio in Q4 2024, its #53 holding.
  • Geller Advisors first reported a position in Merck in Q3 2016 and has held it in 23 quarters since.
  • Geller Advisors's Merck position peaked at $2.48M in Q1 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Geller Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.